Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Filgrastim × Dermatologic × Clear all

Phase

Status

Completed 24 Terminated 8 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 14 Other hematologic neoplasm 10 Plasma cell 7 Genitourinary 6 CNS 6 Breast 6 Thoracic 3 Myeloid 3 Gynecologic 3 Sarcoma 1 Head & Neck 1 Gastrointestinal 1 Dermatologic 1

Conditions

Interventions

Nivolumab 23 pembrolizumab 18 Ipilimumab 14 Temozolomide 12 Cyclophosphamide 9 toripalimab 8 Blood Specimen Collection 8 Biopsy 8 camrelizumab 6 Imiquimod 6 Dacarbazine 6 trametinib 5 fludarabine 5 dabrafenib 5 atezolizumab 5 Cisplatin 5 Chemotherapy, Adjuvant 5 fludarabine phosphate 4 durvalumab 4 apatinib 4 aldesleukin 4 Sorafenib 4 Interleukin-2 4 Injections 4 Bevacizumab 4 Aminolevulinic Acid 4 palbociclib 3 methyl 5-aminolevulinate 3 binimetinib 3 Tomography, Optical Coherence 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00017355 2013-09-17

Vaccine Therapy in Treating Patients With Metastatic Melanoma

National Cancer Institute (NCI)

Phase 1 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡